Invion Limited (ASX: IVX) has signed a funded collaboration with Protect Animal Health Inc. (Taiwan, 7850.TT) to evaluate Photosoft™ in veterinary oncology across in-vitro, in-vivo, and companion-animal studies. Invion supplies compounds, Protect funds, and runs the work. Invion retains all Photosoft IP, with scope to move to a co-development/commercial agreement if results warrant.

American Rare Earths Limited (ASX: ARR) has ticked off three important boxes at Halleck Creek Project (Figure 1): (1) impurity-removal breakthrough, (2) ~3,080 t test-mined and bulk samples dispatched for comminution, (3) third-party LREO/HREO concentrates validating the ore. The October Investor Presentation then ties the technical gains to the scale and economics of a phased development plan.

AuMEGA Metals Limited (ASX: AAM) has reported results from a surficial geochemistry (till) program at Cape Ray West, defining multiple high-grade gold-in-till anomalies along the western contact of the Isle aux Morts Granite — an intrusive body that has never been drill-tested (Figure 1). The anomalies coincide with structural breaks and magnetic features, establishing a new discovery corridor west of existing resources.

icetana Limited (ASX: ICE) has landed its largest Australian sale to date—a five-year SaaS order via Millennium Services Group, a national security and cleaning operator in which SoftBank Robotics holds a controlling stake. The deal totals A$376,000 and is slated for initial deployment next quarter, with licensing expected to commence in the March-2026 quarter.

Encounter Resources Limited (ASX: ENR) has reported multiple intersections of rare earth element (REE) fluorocarbonate minerals (including bastnaesite, synchysite and parasite) from untargeted diamond drilling at the Green carbonatite, alongside a new near-surface REE hit at the Juan prospect, ~10 km from existing niobium-REE deposits in the West Arunta. The results add further evidence that Aileron hosts district-scale niobium–REE potential across several large carbonatite s

Cannindah Resources Limited (ASX: CAE) has reported standout trenching results from the Southern Target Zone (Appletree–Dunno) at Mt Cannindah, Queensland (Figure 1). The work outlines a 500 m × 100 m corridor of high-order Cu-Au-Mo geochemistry coincident with IP chargeability and magnetic highs—and crucially, an untested target at the lowest topographic level within the mining leases, consistent with a preserved porphyry system.

AML3D Limited (ASX: AL3) will supply two custom ARCEMY® systems to Newport News Shipbuilding, extending its footprint in US naval supply chains. The order value is ~A$4.5m, reinforcing momentum after multiple ARCEMY® deployments into the US Navy’s Maritime Industrial Base. The company expects the units to be installed and operational in Q2 2026.

Kaiser Reef Limited (ASX: KAU) has reported materially higher processing performance and a coordinated ramp-up program at the Henty Gold Mine in Tasmania (Figure 1), alongside actions to de-bottleneck underground access, modernise the fleet, and accelerate resource growth drilling. Management frames these steps as critical to lowering unit costs and underpinning near-term Reserve calculations.

Pivotal Metals Limited (ASX: PVT) has released new Fixed-Loop Time Domain EM (FLTEM) results from the Midrim–Alotta area of the Belleterre-Angliers Greenstone Belt (BAGB) Projects in Abitibi, Québec, Canada, ~85 km south of Rouyn-Noranda (Figure 1). The work defines a substantial, untested conductive plate directly beneath the shallow, high-grade Alotta sulphide body, and indicates prior drilling was sub-optimal; a new NE-oriented drill strategy is now planned to test depth

Actinogen Medical (ASX: ACW) released two important updates dated 20 October 2025: (1) accelerated recruitment has enabled early closure of pTau screening for the Phase 2b/3 XanaMIA Alzheimer’s trial; and (2) an Advance Overseas Finding (AOF) approval confirms eligibility for a further RDTI rebate of ~$1.87m, taking the total FY25 RDTI to ~$7.36m if the ATO amendment is favourably assessed.